Replies to post #61022 on Ocata Therapeutics Inc fka OCAT

[lasers]

Personally I am hoping that in 2014 the FDA grants a BLA to $ACTC for their RPE AMD and SMD therapies so those persons that are legally blind can get immediate help with their ophthalmologists. If this happens the PPS for $ACTC will soar into the $Range. $ACTC's RPE for AMD and SMD has been proven to be totally safe with zero adverse events. There are NO "standard of care" current therapies so that there are no other options for these legally blind AMD and SMD persons.